News | News By Subject | News by Disease News By Date | Search News

Varicose Veins News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
BTG plc (BTG.L) Surges As Varicose Vein Treatment Grabs FDA Approval; Stock Up +13.75% At Market Close (November 26, 2013)     11/26/2013
BTG plc (BTG.L) Announces Positive Results From VANISH-2 Study Data Published in the Journal Phlebology     7/26/2013
BTG plc (BGC.L)'s Varicose-vein Drug Succeeds in US Study     1/30/2012
Merz Aesthetics Announces FDA Approval of Asclera(TM) (Polidocanol) Injection, First Sclerosant to Treat Small Varicose Veins in 60 Years     4/23/2010
FDA Approves Chemische Fabrik Kreussler & Co.'s Asclera to Treat Small Varicose Veins     3/31/2010
BTG plc (BGC.L) To Commence US Phase II Clinical Safety Study Of Varisolve(R); Shares Fall As Trial Starts Without Partner     6/19/2006
Yale University School Of Medicine Technology Spins Out Varicose Vein Device Company: Vascular Insights, LLC     4/6/2006

News from Around the Web

Press Releases
BTG plc (BTG.L) Release: Health Canada Approves Varithena (Polidocanol Injectable Foam) For Patients With Varicose Veins     8/6/2015
Protein Sciences Corporation Release: Flublok┬« Influenza Vaccine Will Be Available At Over 230 Passport Health Locations Nationwide     8/19/2014
BTG plc (BTG.L) Release: First Varicose Vein Patient Treated With FDA-Approved Varithena┬« (polidocanol Injectable Foam) 1%     8/11/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Highlights Data From Clinical Trial of Investigational Norovirus Vaccine Candidate     10/4/2013
BTG plc (BGC.L): First Varisolve(R) US Phase III Trial Initiated     9/16/2010
BTG plc (BGC.L) Reports Successful Completion of Treatments in Varisolve┬« US Phase II Safety Study; No Subclinical Effects Found in MRI Scans to Date     6/5/2008
Akorn, Inc. (AKN) Launches Tetanus Diphtheria Vaccine     9/5/2007
HepaLife Technologies Inc. (HPLF.OB)'s PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference     6/25/2007
GenVec Inc. (GNVC) Announces Additional Funding for Malaria Vaccine Program from the PATH Malaria Vaccine Initiative     5/1/2007
Merck & Co., Inc. (MRK)'s Cervical Cancer Vaccine, GARDASIL(R), Added To The Centers for Disease Control and Prevention (CDC) Vaccines For Children Contract     11/1/2006
Published Five-Year Multi-Center Results Demonstrate The VNUS Medical Technologies (VNUS) Closure Procedure Produces Highly Successful And Durable Outcomes For Patients With Venous Reflux And Varicose Veins     9/21/2005
Diomed Inc. (DIO) Receives Notice Of Allowance For Key U.S. EVLT Patent     7/26/2005
Bioniche Life Sciences Inc. (BNC.TO) Launches Sotradecol(R) Injection For Varicose Veins In U.S. Market     7/14/2005